![Autologous Stem Cell Transplantation in the Treatment of Pulmonary Light Chain Deposition Disease - CHEST Autologous Stem Cell Transplantation in the Treatment of Pulmonary Light Chain Deposition Disease - CHEST](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ae49d2da-110e-4eb7-9841-3ec9ff461841/gr1_lrg.jpg)
Autologous Stem Cell Transplantation in the Treatment of Pulmonary Light Chain Deposition Disease - CHEST
![Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d96fcc03-e4e5-4539-873f-ef3382636fb5/jnc15500-toc-0001-m.jpg)
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library
![The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-019-02147-4/MediaObjects/12967_2019_2147_Fig1_HTML.png)
The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text
![Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment - Gertz - 2018 - American Journal of Hematology - Wiley Online Library Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment - Gertz - 2018 - American Journal of Hematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/5b6979eb-b3b6-4b4f-9146-a5f478e38611/ajh25149-fig-0002-m.jpg)
Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment - Gertz - 2018 - American Journal of Hematology - Wiley Online Library
![Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS](https://www.pnas.org/cms/10.1073/pnas.1901734117/asset/93090c45-a6be-4e49-8f52-c691ade50509/assets/graphic/pnas.1901734117fig01.jpeg)
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS
Natural history and prognostic impact of oligoclonal humoral response in patients with multiple myeloma after autologous stem cell transplantation: long-term results from a single institution | Haematologica
![Frontiers | Successful Treatment of Relapsed/Refractory Extramedullary Multiple Myeloma With Anti-BCMA CAR-T Cell Therapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report and a Review of the Contemporary Literature Frontiers | Successful Treatment of Relapsed/Refractory Extramedullary Multiple Myeloma With Anti-BCMA CAR-T Cell Therapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report and a Review of the Contemporary Literature](https://www.frontiersin.org/files/Articles/649824/fmed-08-649824-HTML-r1/image_m/fmed-08-649824-g001.jpg)
Frontiers | Successful Treatment of Relapsed/Refractory Extramedullary Multiple Myeloma With Anti-BCMA CAR-T Cell Therapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report and a Review of the Contemporary Literature
![Acute Acquired Fanconi Syndrome in Multiple Myeloma After Hematopoietic Stem Cell Transplantation - Kidney International Reports Acute Acquired Fanconi Syndrome in Multiple Myeloma After Hematopoietic Stem Cell Transplantation - Kidney International Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cc18bdd3-d585-4c18-9eb9-40f45b88846b/gr1_lrg.jpg)
Acute Acquired Fanconi Syndrome in Multiple Myeloma After Hematopoietic Stem Cell Transplantation - Kidney International Reports
![Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 11.5 (2019) Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 11.5 (2019)](https://jnccn.org/view/journals/jnccn/17/11.5/full-jnccn20195034f3.jpg)
Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 11.5 (2019)
![Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myeloma - Cytotherapy Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myeloma - Cytotherapy](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/bee9f53b-aef6-47a7-a53a-e24e20f404b0/gr1_lrg.jpg)
Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myeloma - Cytotherapy
![Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA–CAR-T therapy in patient with relapsed myeloma | Bone Marrow Transplantation Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA–CAR-T therapy in patient with relapsed myeloma | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41409-019-0674-2/MediaObjects/41409_2019_674_Fig1_HTML.png)
Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA–CAR-T therapy in patient with relapsed myeloma | Bone Marrow Transplantation
![Hematologic parameters and free kappa/lambda light chain ratio over the... | Download Scientific Diagram Hematologic parameters and free kappa/lambda light chain ratio over the... | Download Scientific Diagram](https://www.researchgate.net/publication/23976514/figure/fig2/AS:202696205312001@1425337949975/Hematologic-parameters-and-free-kappa-lambda-light-chain-ratio-over-the-course-of.png)
Hematologic parameters and free kappa/lambda light chain ratio over the... | Download Scientific Diagram
![Sustained Response to Selinexor-Based Therapy for Triple-Class Refractory Multiple Myeloma with Early Relapse After Allogeneic Stem Cell Transplantation - Clinical Lymphoma, Myeloma and Leukemia Sustained Response to Selinexor-Based Therapy for Triple-Class Refractory Multiple Myeloma with Early Relapse After Allogeneic Stem Cell Transplantation - Clinical Lymphoma, Myeloma and Leukemia](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/16a815bc-a032-4e57-9ec6-eb335e359e01/gr1_lrg.jpg)
Sustained Response to Selinexor-Based Therapy for Triple-Class Refractory Multiple Myeloma with Early Relapse After Allogeneic Stem Cell Transplantation - Clinical Lymphoma, Myeloma and Leukemia
Full article: The cut-offs for kappa/lambda ratio in bone marrow immunohistochemistry for the diagnosis of multiple myeloma
![The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases - ScienceDirect The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332216323745-gr3.jpg)
The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases - ScienceDirect
![PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/92e61d19dc92e499c7b7b01818ac923837d9f518/3-Table3-1.png)
PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar
![SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain](https://minio.scielo.br/documentstore/1806-0870/bmKRgcYXXQnRYh8pxk4mj5Q/5bd873428955d5251700c948e7a67ec7a186cd92.jpg)
SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain
![PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/92e61d19dc92e499c7b7b01818ac923837d9f518/3-Figure1-1.png)
PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar
![International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2008.307/MediaObjects/41375_2009_Article_BFleu2008307_Fig1_HTML.jpg)
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
![The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases - ScienceDirect The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332216323745-gr2.jpg)